HC Wainwright Has Positive Forecast for CASI Q2 Earnings
CASI Pharmaceuticals, Inc. (NASDAQ:CASI – Free Report) – Analysts at HC Wainwright lifted their Q2 2025 EPS estimates for CASI Pharmaceuticals in a research report issued on Monday, May 19th. HC Wainwright analyst S. Lee now anticipates that the biotechnology company will post earnings of ($0.47) per share for the quarter, up from their prior […]
CASI Pharmaceuticals, Inc. (NASDAQ:CASI – Free Report) – Analysts at HC Wainwright lifted their Q2 2025 EPS estimates for CASI Pharmaceuticals in a research report issued on Monday, May 19th. HC Wainwright analyst S. Lee now anticipates that the biotechnology company will post earnings of ($0.47) per share for the quarter, up from their prior […]
